Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Prostaglandin E2 activates four distinct G protein-coupled receptors, EP1-4. Rivenprost is a potent and selective agonist for the EP4 receptor (Ki = 0.7, 56, 620, and >10,000 nM for EP4, EP3, EP2, and EP1, respectively). It has been used to promote EP4-mediated bone formation, prevent bone loss related to osteoporosis, drive osteoblast differentiation, and stabilize bone implants.[1][2][3][4][5] Rivenprost has also been used to support wound healing.[6]
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
100 μg | 約 35 days | ¥ 22,500 |
500 μg | 約 35 days | ¥ 86,000 |
1 mg | 約 35 days | ¥ 160,500 |
説明 | Prostaglandin E2 activates four distinct G protein-coupled receptors, EP1-4. Rivenprost is a potent and selective agonist for the EP4 receptor (Ki = 0.7, 56, 620, and >10,000 nM for EP4, EP3, EP2, and EP1, respectively). It has been used to promote EP4-mediated bone formation, prevent bone loss related to osteoporosis, drive osteoblast differentiation, and stabilize bone implants.[1][2][3][4][5] Rivenprost has also been used to support wound healing.[6] |
別名 | ONO-4819 |
分子量 | 450.59 |
分子式 | C24H34O6S |
CAS No. | 256382-08-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: 30 mg/mL
Ethanol: 30 mg/mL
DMSO: 20 mg/Ml
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rivenprost 256382-08-8 ONO-4819 ONO4819 ONO 4819 Inhibitor inhibitor inhibit